Compare SSRM & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SSRM | TXG |
|---|---|---|
| Founded | 1946 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 6.0B |
| IPO Year | 1997 | 2019 |
| Metric | SSRM | TXG |
|---|---|---|
| Price | $31.85 | $58.16 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 15 |
| Target Price | ★ $32.74 | $20.25 |
| AVG Volume (30 Days) | 3.2M | ★ 3.2M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 243.41 | 76.97 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,629,637,000.00 | $245,893,000.00 |
| Revenue This Year | $56.48 | N/A |
| Revenue Next Year | $4.31 | $7.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 63.68 | ★ 68.06 |
| 52 Week Low | $15.99 | $11.17 |
| 52 Week High | $36.52 | $60.69 |
| Indicator | SSRM | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 62.26 | 73.49 |
| Support Level | $28.41 | $17.54 |
| Resistance Level | $33.66 | N/A |
| Average True Range (ATR) | 1.31 | 3.60 |
| MACD | 0.71 | 0.77 |
| Stochastic Oscillator | 85.52 | 85.00 |
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).